Cargando…
Pharmacologic Treatment and Management of Coronavirus Disease 2019
Over the last 2 years, there has been gradual and sustained progress toward our understanding of pharmacotherapy for coronavirus disease 2019 (COVID-19) as a result of large- and small-scale randomized controlled trials. Numerous new and repurposed treatments have been evaluated; some have demonstra...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Health Sciences Division
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828431/ https://www.ncbi.nlm.nih.gov/pubmed/35636904 http://dx.doi.org/10.1016/j.idc.2022.02.001 |